XOMA Community Page | What other sites are saying about XOMA

XOMA	(NQ: XOMA)

4.090 USD -0.040 (-0.97%)

Official Closing Price / Updated: 8:10 PM EDT, May 24, 2013 / Add to My Watchlist

(XOMA) Community Analysis from

Related Wikinvest articles

May 25, 2013

(XOMA) XOMA’s Gevokizumab Study Update

(Stock Blog Hub, 1/15/13)

XOMA Corporation (XOMA) recently announced interim data from a phase II proof-of-concept (POC) study on gevokizumab, which is being developed for the treatment of inflammatory facial lesions...(read more)

XOMA Acquires U.S. Rights to Perindopril Franchise and Establishes Commercial Operations

(Phil’s Stock World, 1/17/12)

Courtesy of Benzinga. XOMA Corporation (Nasdaq: XOMA) today announced it has acquired U.S. rights to the perindopril franchise from...(read more)

XOMA Will Move Its Corporate Domicile to Delaware

(Phil’s Stock World, 12/30/11)

Courtesy of Benzinga. XOMA Ltd. (Nasdaq: XOMA) today announced that, effective December 31, 2011, it will move its corporate domicile from Bermuda to Delaware and change its name from "XOMA Ltd." to "XOMA Corporation." All of the outstanding common shares of the [...]

View all posts about XOMA (XOMA)

XOMA (XOMA) Company Overview

There is no analysis for XOMA yet. But you can go to Wikinvest to help create one!

What's in this XOMA analysis on Wikinvest...